Claudine Isaacs, MD: For this patient who's progressed after more than 12 months with an ESR1 mutation and HER2-low disease ...
High School DxD Season 3 was notably the final season produced under TNK, and more notably featured some material that was not from the original light novel releases. High School DxD Hero then finally ...
The whole thing went live on social media as High School DxD celebrated its next series. On May 17th, Junior High School DxD – The Transfer Student is a Samurai Girl will go live. We learned about the ...
New analysis of the DESTINY-Breast06 trial demonstrated that trastuzumab deruxtecan (T-DXd) provides meaningful clinical benefit regardless of time to progression on prior endocrine therapy, offering ...
The antibody-drug conjugate trastuzumab deruxtecan (T-DXd, Enhertu) proved active in a phase II study of advanced HER2-positive colorectal cancer (CRC). Almost 40% of patients treated with the ...
Dato-DXd lengthened the average time it took patients with HR-positive, HER2-low or -negative metastatic breast cancer to experience disease progression, study results showed. Patients with hormone ...
With recent expansions in its breast cancer indications, there has been an increase in the use of trastuzumab deruxtecan (T-DXd; Enhertu). "A lot of us are using this more frequently now than we were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback